Soros Fund Management - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98422LAA5. A total of 4 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Soros Fund Management ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$13,597,000
+96.0%
6,986,000
-0.2%
0.33%
+114.8%
Q2 2020$6,939,0007,000,0000.16%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
683 Capital Management, LLC 2,950,000$3,038,5000.24%
Saltoro Capital, LP 250,000$243,7500.22%
LAZARD ASSET MANAGEMENT LLC 11,500,000$11,2120.02%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of XERIS PHARMACEUTICALS INC shareholders